ArticleJournal of pharmaceutical analysis2025

Oxymatrine, a novel TLR2 agonist, promotes megakaryopoiesis and thrombopoiesis through the STING/NF-κB pathway.

Chengyang Ni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.